Zhukovsky, Peter http://orcid.org/0000-0002-7181-2095
Coughlan, Gillian
Dickie, Erin W.
Hawco, Colin
Voineskos, Aristotle N.
Funding for this research was provided by:
CIHR (Postdoctoral Fellowship)
Alzheimers Society
National Institutes of Health
Centre for Addiction and Mental Health Foundation
National Institute of Mental Health
Article History
Accepted: 3 February 2022
First Online: 29 March 2022
Declarations
:
: This work used open access data from the OASIS3 study. Ethical Approval for OASIS3 study was obtained from the relevant Review Ethical Board by the OASIS3 Principal Investigators: T. Benzinger, D. Marcus, J. Morris; NIH P50 AG00561, P30 NS09857781, P01 AG026276, P01 AG003991, R01 AG043434, UL1 TR000448, R01 EB009352. AV-45 doses were provided by Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly. ExternalRef removedConsent to participate was obtained from all the OASIS3 participants by the open access study.
: All authors consent to publishing this study.
: Authors declare no conflicts of interest.